EUCTR2010-022655-29-NL进行中（未招募）不适用
Randomised open label cross-over study into the efficacy of RApamycin in children with Tuberous sclerosis complex with intractable Epilepsy (RATE-trial) - RATE
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- Erasmus MC
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Children with definite TSC older than 3 months, up to 12 yrs old, with catastrophic epilepsy (West syndrome or intractable epilepsy defined as 1 or more seizures/week despite two adequate trials of anti-epileptic drug regimens).
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Renal dysfunction, surgery during 6wk before inclusion, current infection.
研究者
相似试验
已完成
2 期
Randomised open label cross-over study into the efficacy of RApamycin in children with Tuberous sclerosis complex with intractable EpilepsyEpilepsy causes by Tuberous Sclerosis Complex10039911NL-OMON36614Erasmus MC, Universitair Medisch Centrum Rotterdam30
已完成
不适用
Study into treatment of children with difficult to treat epilepsy due to Tuberous sclerosis complex with Rapamycin.TSCTuberous sclerosis complexTubereuze sclerose complexRapamycinRapamycineEpilepsyEpilepsiemTORmTORC1NL-OMON28870Erasmus University Medical Center23
进行中（未招募）
1 期
A Study of Xenical (Orlistat) in Overweight and Obese AdolescentsEUCTR2016-001661-91-Outside-EU/EEAF. Hoffmann-La Roche AG80
尚未招募
2 期
Kushtadi churna and pippalyadi churna pratisarana in tundikeri vis-a-vis chronic tonsillitisCTRI/2024/05/067358Dr MD Shahid Musaib
尚未招募
4 期
Role of Melbild Solution in the treatment of VitiligoCTRI/2017/06/008845Alkem Laboratories Limited120